These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17938769

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Central venous access catheters in children with haemophilia.
    Blanchette VS, al-Musa A, Stain AM, Filler RM, Ingram J.
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S39-44. PubMed ID: 8735796
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Immune tolerance therapy for inhibitors in haemophilia A].
    Oldenburg J.
    Hamostaseologie; 2008 Oct; 28 Suppl 1():S23-5. PubMed ID: 18958334
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
    Gringeri A, Musso R, Mazzucconi MG, Piseddu G, Schiavoni M, Pignoloni P, Mannucci PM, RITS-FITNHES Study Group.
    Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor.
    Aleem A, Saidu A, Abdulkarim H, Al-Diab AR, Al-Sagheer A, Qayum A, Al-Momen AK.
    Haemophilia; 2009 Jan; 15(1):210-6. PubMed ID: 19149851
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitors in mild/moderate haemophilia A: an update.
    Franchini M, Salvagno GL, Lippi G.
    Thromb Haemost; 2006 Aug; 96(2):113-8. PubMed ID: 16894451
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA, Saint-Remy JM, Jacquemin M, Benhida A, DiMichele DM.
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [Abstract] [Full Text] [Related]

  • 17. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.
    Komvilaisak P, Connolly B, Naqvi A, Blanchette V.
    Haemophilia; 2006 Dec; 12 Suppl 6():87-93. PubMed ID: 17123400
    [Abstract] [Full Text] [Related]

  • 18. Catastrophic microangiopathy induced by high-titre factor VIII inhibitors after liver transplantation for haemophilia A with cirrhosis.
    Khakhar AK, Chan NG, Allan DS, Chakrabarti S, McAlister VC.
    Haemophilia; 2005 Nov; 11(6):623-8. PubMed ID: 16236113
    [Abstract] [Full Text] [Related]

  • 19. Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor.
    Ashrani AA, Reding MT, Shet A, Osip J, Humar A, Lake JR, Key NS.
    Haemophilia; 2004 Nov; 10(6):735-7. PubMed ID: 15569170
    [Abstract] [Full Text] [Related]

  • 20. Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia.
    Ljung R, Petrini P, Lindgren AK, Berntorp E.
    Acta Paediatr; 1992 Nov; 81(11):918-20. PubMed ID: 1467614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.